PETER P. PFREUNDSCHUH
CIK 1585839 · EVP, CFO and Treasurer · last filed 2025-09-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$966.4K
Companies
6
Total Filings
33
Lifetime Open-Market Net
-$317.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | CFO and Treasurer | 77,800 | $8.61 | $669.9K | $0 | 2 | 2025-01-22 |
| VYGR | Chief Financial Officer | 175,669 | $3.50 | $614.8K | -$122.9K | 6 | 2024-02-22 |
| Korro Bio, Inc. (FREQ) Delisted | Chief Financial Officer | 10,469 | $14.98 | $156.8K | -$27.6K | 6 | 2022-02-23 |
| URGN | Chief Financial Officer | 11,829 | $29.72 | $351.6K | -$166.7K | 11 | 2020-10-16 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | CFO | 0 | — | — | $0 | 3 | 2018-02-13 |
| IMMUNOMEDICS INC (IMMU) Delisted | Chief Financial Officer | 29,706 | — | — | $0 | 4 | 2015-08-24 |
Recent Filings · Page 3 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-24 | URGN | Mixed | +682 | -$10.7K | EDGAR |
| 2020-02-04 | URGN | Grant (A) | — | $0 | EDGAR |
| 2020-01-28 | URGN | Mixed | +999 | -$19.5K | EDGAR |
| 2019-11-22 | URGN | Mixed | +688 | -$10.1K | EDGAR |
| 2019-08-22 | URGN | Mixed | +2,751 | -$46.8K | EDGAR |
| 2019-01-29 | URGN | Grant (A) | — | $0 | EDGAR |
| 2018-02-13 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Disp (D) | −263 | -$4.7K | EDGAR |
| 2018-01-12 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +394 | $3.6K | EDGAR |
| 2017-03-22 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-24 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | +15,341 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.